Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Efsubaglutide Alfa

Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents

Shanghai Yinnuo Pharmaceutical Technology Co · Phase 1 · Recruiting · Enrollment 36

NCT07693426

ArmPopulationDoseWeeksEstimandWeight change
Efsubaglutide Alfa 5 mg QWObesity or overweight5 mg12n/rn/r
Efsubaglutide Alfa 10 mg QWObesity or overweight10 mg12n/rn/r
Efsubaglutide Alfa 20 mg QWObesity or overweight20 mg12n/rn/r
Efsubaglutide Alfa placeboObesity or overweightn/r12n/rn/r